Anaïs Maurier
YOU?
Author Swipe
View article: Response to Letter “Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out”
Response to Letter “Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out” Open
View article: Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series Open
View article: Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts’ Opinion and Systematic Review from the Literature
Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts’ Opinion and Systematic Review from the Literature Open
Background: Vascular anomalies (VAs) are increasingly being treated with PI3K/AKT/mTOR pathway inhibitors. These drugs have immunosuppressive properties and thus theoretically overexpose patients to opportunistic infections, …
View article: Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database
Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database Open
Limited data are available on adverse drug reactions (ADRs) of gender‐affirming hormone therapy (HT), mainly due to the lack of population‐based studies with adequate controls, thus making spontaneous reporting systems a valuable tool to d…
View article: Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review Open